Aeterna Zentaris Abstract Accepted for Presentation at : vim

– Company advancing development of its Autoimmunity Modifying AIM Biologicals as a potential therapeutic treatment option for Parkinson’s Disease ("PD"), a...

Related Keywords

Oregon , United States , Portland , Canada , Toronto , Ontario , Oregon Convention Center , Ukraine , Canadian , American , Jenene Thomas , Klaus Paulini , Valentin Bruttel , Lou Gehrig , Chi Wang Ip , Joerg Wischhusen , C Wang Ip , S Mamatha Jayaram , Event Of The American Association Immunologists , School Of Medicine , Department Of Neurology , Company On Twitter , Linkedin , Aeterna Zentaris , Nasdaq , University Of Wuerzburg The , Aeterna Zentaris Inc , American Association Of Immunologists Inc , Facebook , Department Of Obstetrics , European Commission , American Association Of Immunologists , University Of Wuerzburg , Toronto Stock Exchange , Novo Nordisk , Autoimmunity Modifying , Annual Event , American Association , Experimental Tumor Immunology , Therapeutic Approaches , Based Therapeutics , Chief Executive Officer , Litigation Reform Act , Novo Amended License Agreement , Annual Report , Annual Meeting , Nasdaq Aezs , Tsezs , Mmunology2022 , Im Biologicals , Diagnostic Products , Parkinsons Disease , Iopharmaceutical , Medicine ,